Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Cystic Fibrosis Market: By Drug Class: Bronchodilators, Mucolytics, Pancreatic Enzyme Supplement, Others; By Route of Administration; By Drug Molecule Type; By End-User; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Cystic Fibrosis Market Outlook
The global cystic fibrosis market reached a value of about USD 6.6 billion in 2021. The market is further expected to grow at a CAGR of 9.10% in the forecast period of 2022-2027 to reach a value of around USD 11.1 billion by 2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Oral Segment to Bolster the Market Growth of Cystic Fibrosis
Based on the route of administration, the oral segment is leading the market for cystic fibrosis. The efficiency of orally administered medication in improving the quality of life and reducing the intensity of symptoms is providing impetus to the market growth of cystic fibrosis. In addition, the accessibility of oral medications such as Ataluren (PTC124), Kalydeco, and N-acetylcysteine is also accelerating the development of the market. Moreover, the rising inclination of patients towards oral treatments over intravenous therapy is resulting in the steady growth of the market. The reasons for the preference can be the convenience associated with the intake of oral medication, which is less time consuming and is cost-effective as the medication can be taken without being at hospitals. Further, the increasing formulation of drugs in oral form is projected to positively impact the market for cystic fibrosis.
Europe to Account for a Substantial Market Share in the Cystic Fibrosis Industry
The increasing cases of cystic fibrosis disease in the European region and the developed healthcare infrastructure is contributing to the market expansion of cystic fibrosis. In addition, the government initiatives in countries such as United Kingdom to improve the lives of people living with rare diseases is bolstering the market. The adoption of new technologies and digital tools for faster diagnosis, and improvements to virtual consultations is resulting in the market expansion.
Cystic Fibrosis: Market Segmentation
Cystic fibrosis, also called CF, is a life-threatening disease that affects the exocrine glands. The hereditary disease occurs when mutations occur in the CFTR gene, causing defective cystic fibrosis transmembrane conductance regulator (CFTR) proteins. The disease affects the cells that produce digestive juices, mucus, and sweat, making these fluids abnormally thick. This fluid further blocks ducts, passageways, intestines, and bronchi, thus resulting in respiratory infection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market for cystic fibrosis, by drug class, is divided into:
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- Bronchodilators
- Mucolytics
- Pancreatic Enzyme Supplement
- Antibiotics
- Others
Based on route of administration, the market is segmented into:
- Oral
- Parenteral
On the basis of drug molecule type, the market is classified into:
- Small Molecule Drugs
- Biologics
Based on end-user, the market is segmented into:
- Hospitals
- Clinics
- Others
On the basis of distribution channel, the market is divided into:
- Hospital Pharmacies
- Retail Pharmacies and Drug Stores
- Online Pharmacies
The regional markets for cystic fibrosis can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Cases of Cystic Fibrosis to Drive the Market Growth of Cystic Fibrosis
The rising case of cystic fibrosis worldwide is significantly catalysing the market growth of cystic fibrosis. As per the Centers for Disease Control and Prevention, in the United States, cystic fibrosis affects about 35,000 people in the region. In addition, the expanding diagnosis of the disease through government initiatives and the growing awareness about the available treatment options for cystic fibrosis is invigorating the market. Moreover, the improving access to specialist care and medications owing to the developing healthcare infrastructure and economic development is providing impetus to the market.
Also, the formulation of policies by governments across the globe for the treatment of rare diseases is playing a critical role in the market growth of cystic fibrosis. Further, the advancements in the diagnosis and treatment of cystic fibrosis disease to increase the survival of patients and the investments in research activities to develop drugs by the leading industry players are estimated to stimulate the market growth in the forecast period.
Key Industry Players in the Global Cystic Fibrosis Market
The report gives a detailed analysis of the following key players in the global cystic fibrosis market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Vertex Pharmaceuticals Incorporated
- AbbVie Inc.
- Novartis AG
- Mylan N.V.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Cystic Fibrosis Market Analysis
8.1 Key Industry Highlights
8.2 Global Cystic Fibrosis Historical Market (2017-2021)
8.3 Global Cystic Fibrosis Market Forecast (2022-2027)
8.4 Global Cystic Fibrosis Market by Drug Class
8.4.1 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Bronchodilators
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Mucolytics
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Pancreatic Enzyme Supplement
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 Antibiotics
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2017-2021)
8.4.5.3 Forecast Trend (2022-2027)
8.4.6 Others
8.5 Global Cystic Fibrosis Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.6 Global Cystic Fibrosis Market by Drug Molecule Type
8.6.1 Small Molecule Drugs
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Biologics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.7 Global Cystic Fibrosis Market by End-User
8.7.1 Hospitals
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Clinics
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Others
8.8 Global Cystic Fibrosis Market by Distribution Channel
8.8.1 Hospital Pharmacies
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2017-2021)
8.8.1.3 Forecast Trend (2022-2027)
8.8.2 Retail Pharmacies and Drug Stores
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2017-2021)
8.8.2.3 Forecast Trend (2022-2027)
8.8.3 Online Pharmacies
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2017-2021)
8.8.3.3 Forecast Trend (2022-2027)
8.9 Global Cystic Fibrosis Market by Region
8.9.1 Market Share
8.9.1.1 North America
8.9.1.2 Europe
8.9.1.3 Asia Pacific
8.9.1.4 Latin America
8.9.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Vertex Pharmaceuticals Incorporated
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 AbbVie Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Novartis AG
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Mylan N.V.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Pfizer Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Teva Pharmaceutical Industries Ltd.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Cystic Fibrosis Market: Key Industry Highlights, 2017 and 2027
2. Global Cystic Fibrosis Historical Market: Breakup by Drug Class (USD Billion), 2017-2021
3. Global Cystic Fibrosis Market Forecast: Breakup by Drug Class (USD Billion), 2022-2027
4. Global Cystic Fibrosis Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
5. Global Cystic Fibrosis Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
6. Global Cystic Fibrosis Historical Market: Breakup by Drug Molecule Type (USD Billion), 2017-2021
7. Global Cystic Fibrosis Market Forecast: Breakup by Drug Molecule Type (USD Billion), 2022-2027
8. Global Cystic Fibrosis Historical Market: Breakup by End-User (USD Billion), 2017-2021
9. Global Cystic Fibrosis Market Forecast: Breakup by End-User Type (USD Billion), 2022-2027
10. Global Cystic Fibrosis Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
11. Global Cystic Fibrosis Market Forecast: Breakup by Distribution Channel Distribution Channel (USD Billion), 2022-2027
12. Global Cystic Fibrosis Historical Market: Breakup by Region (USD Billion), 2017-2021
13. Global Cystic Fibrosis Market Forecast: Breakup by Region (USD Billion), 2022-2027
14. North America Cystic Fibrosis Historical Market: Breakup by Country (USD Billion), 2017-2021
15. North America Cystic Fibrosis Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Europe Cystic Fibrosis Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Europe Cystic Fibrosis Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Asia Pacific Cystic Fibrosis Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Asia Pacific Cystic Fibrosis Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Latin America Cystic Fibrosis Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Latin America Cystic Fibrosis Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Middle East and Africa Cystic Fibrosis Historical Market: Breakup by Country (USD Billion), 2017-2021
23. Middle East and Africa Cystic Fibrosis Market Forecast: Breakup by Country (USD Billion), 2022-2027
24. Global Cystic Fibrosis Market Structure
Key Questions Answered in the Report
In 2021, the global cystic fibrosis market attained a value of nearly USD 6.6 billion.
The market is estimated to grow at a CAGR of 9.10% between 2022 and 2027.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach almost USD 11.1 billion by 2027.
The major industry drivers are developing healthcare infrastructure, adoption of new technologies and digital tools for faster diagnosis, growing awareness about the available treatment options for cystic fibrosis, and research activities for the efficient treatment of the disease.
The key industry trends guiding the growth of the market are rising cases of cystic fibrosis, government initiatives, and increasing drug developments by industry players.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The different drug classes in the market include cystic fibrosis transmembrane conductance regulator (CFTR), bronchodilators, mucolytics, pancreatic enzyme supplement, and antibiotics, among others.
The significant routes of administration for cystic fibrosis include oral and parenteral.
The major market divisions, based on drug molecule type, include small molecule drugs and biologics.
The different market divisions, based on end-user, include hospitals and clinics, among others.
The different distribution channels of the market are hospital pharmacies, retail pharmacies and drug stores, and online pharmacies.
The major players in the industry are Vertex Pharmaceuticals Incorporated, AbbVie Inc., Novartis AG, Mylan N.V., Pfizer Inc., and Teva Pharmaceutical Industries Ltd., among others.
Analyst Review
The global cystic fibrosis market attained a value of nearly USD 6.6 billion in 2021, driven by the increasing cases of cystic fibrosis. Aided by the innovative drug developments, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 9.10%. The market is projected to reach about USD 11.1 billion by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The cystic fibrosis industry, by drug class, is divided into cystic fibrosis transmembrane conductance regulator (CFTR), bronchodilators, mucolytics, pancreatic enzyme supplement, and antibiotics, among others. Based on the route of administration, the market is segmented into oral and parenteral. On the basis of drug molecule type, the market is classified into small molecule drugs and biologics. Based on end-user, the market is segmented into hospitals and clinics, among others. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and drug stores, and online pharmacies. The major regional markets for cystic fibrosis are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Vertex Pharmaceuticals Incorporated, AbbVie Inc., Novartis AG, Mylan N.V., Pfizer Inc., and Teva Pharmaceutical Industries Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global bleeding disorders therapeutics market is expected to grow at a CAGR of 7.4% during the period 2022-2027. North America and Europe are expected to be key markets.
India peritoneal dialysis market is driven by increasing government initiatives and guidelines. Aided by the surge in incidences of kidney-related diseases and the increasing geriatric population, the...
The Asia Pacific scoliosis management market was driven by the increasing demand for non-invasive therapies in the historical period. Aided by the high adoption rate of braces and advancement of techn...
The global craniomaxillofacial implants market attained a value of USD 2.5 billion in 2021, driven by the increase in the number of trauma cases and road accidents. Aided by the growing sports injurie...
The global cancer cachexia market was driven by the rising instances of cachexia and developments in modern treatment systems in the historical period. Aided by continuous clinical trials in oncology ...
NEWSLETTER